FDA approves treatment for Parkinson's drug side effect

The Food and Drug Administration approved Adamas Pharmaceuticals' drug Gocovri to treat dyskinesia, a side effect of a medication prescribed to most Parkinson's disease patients, reports Reuters.

Here are three things to know.

  1. The Parkinson's drug levodopa can cause dyskinesia, or uncontrolled, involuntary movement.

  1. Gocovri is a once-daily drug intended to control levodopa-induced dyskinesia. The drugs main ingredient, amantadine, has been on the market for several decades as an antiviral drug.

  1. Adamas Pharmaceuticals expects the drug to be available in the fourth quarter of this year and formally launch in January 2018.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars